Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.
Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...
AMD claims the Ryzen 9000 CPUs are up to 8% faster than the previous Ryzen 9 7950X3D, with improvements in games like Black ...
AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the ...
Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, today announced a strategic collaboration with AMD to deploy AMD Instinct™ accelerators and ROCm™ software to power ...
At the top of the lineup is the Ryzen AI Max+ 395, featuring 16 CPU cores, 40 GPU cores, and support for up to 128GB of ...
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/97.BYxs733P.js ...